Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04742075 |
|---|---|
| Brief Title: | Olaparib, Durvalumab and UV1 in Relapsed Ovarian Cancer (DOVACC) |
| First Submitted : | October 9, 2020 |
| First Submitted that Met QC Criteria : | February 3, 2021 |
| First Posted : | February 5, 2021 |
| Last Update Submitted that Met QC Criteria : | September 7, 2023 |
| Last Update Posted : | September 8, 2023 |